---
schema_version: "secwatch.filing_event.v1"
accession: "0001079973-25-001724"
form_type: "8-K"
ticker: "TOI"
cik: "0001799191"
company_name: "Oncology Institute, Inc."
filed_at: "2025-11-14T23:59:59+00:00"
generated_at: "2026-05-16T19:54:09.929243+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# Oncology Institute provides investor presentation with no specific new financial disclosures

## Summary
- Investor presentation furnished under Regulation FD on November 14, 2025.
- Presentation content not disclosed in filing; exhibit text appears corrupted or incomplete.
- No accompanying earnings release, guidance change, or material event noted.
- Company common stock (TOI) and warrants (TOIIW) listed on Nasdaq.

## SEC filing metadata
- accession: 0001079973-25-001724
- form_type: 8-K
- ticker: TOI
- cik: 0001799191
- company_name: Oncology Institute, Inc.
- filed_at: 2025-11-14T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1799191/000107997325001724/0001079973-25-001724-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1799191/000107997325001724/toi_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001079973-25-001724
- JSON: https://secwatch.observer/filing/0001079973-25-001724.json
- Plain text: https://secwatch.observer/filing/0001079973-25-001724.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.